SONN Archived Articles
Sonnet BioTherapeutics Holdings, Inc.: Pioneering Targeted Immunotherapies with FHAB Technology
Published on March 16, 2025
Sonnet BioTherapeutics: Advancing Innovative Immunotherapies with Proprietary F H AB Platform
Published on November 30, 2024
Sonnet BioTherapeutics: A Promising Oncology-Focused Biotech with Innovative Biologic Drugs
Published on September 24, 2024